menu search

NBTX / Why is Nanobiotix (NBTX) Stock Up 107% Today?

Why is Nanobiotix (NBTX) Stock Up 107% Today?
Nanobiotix (NASDAQ: NBTX ) stock is taking off on Friday after the company revealed details about ongoing contract negotiations for NBTXR3. NBTXR3 is Nanobiotix's treatment in the works for solid tumors. Read More
Posted: May 5 2023, 08:26
Author Name: InvestorPlace
Views: 103096

NBTX News  

Nanobiotix S.A. (NBTX) Q2 2023 Earnings Call Transcript

By Seeking Alpha
September 27, 2023

Nanobiotix S.A. (NBTX) Q2 2023 Earnings Call Transcript

Nanobiotix S.A. (NASDAQ:NBTX ) Q2 2023 Earnings Conference Call September 27, 2023 8:00 AM ET Company Participants Craig West - SVP, IR Laurent Levy - more_horizontal

Nanobiotix: At A Crucial Juncture For Data

By Seeking Alpha
August 24, 2023

Nanobiotix: At A Crucial Juncture For Data

Nanobiotix is an oncology-focused biotech aiming for its first drug approval, with a tripled value since the beginning of 2023. Their flagship molecul more_horizontal

Nanobiotix stock skyrockets on final negotiations with ‘major' drug maker for its cancer treatment

By Proactive Investors
May 5, 2023

Nanobiotix stock skyrockets on final negotiations with ‘major' drug maker for its cancer treatment

Nanobiotix SA (EPA:NANO) shares soared 250% to $7.11, on volume of more than 29 million shares, Friday after the France-based clinical biotechnology c more_horizontal

Nanobiotix stock more than triples, after biotech enters final negotiations with ‘major' drug maker on development of cancer treatment

By Market Watch
May 5, 2023

Nanobiotix stock more than triples, after biotech enters final negotiations with ‘major' drug maker on development of cancer treatment

The U.S.-listed shares of Nanobiotix S.A. NBTX blasted 221.7% higher on massive volume Friday, to pace all gainers trading on major U.S. exchanges, af more_horizontal

Why is Nanobiotix (NBTX) Stock Up 107% Today?

By InvestorPlace
May 5, 2023

Why is Nanobiotix (NBTX) Stock Up 107% Today?

Nanobiotix (NASDAQ: NBTX ) stock is taking off on Friday after the company revealed details about ongoing contract negotiations for NBTXR3. NBTXR3 is more_horizontal

Nanobiotix S.A (NBTX) CEO Laurent Levy on Q4 2021 Results - Earnings Call Transcript

By Seeking Alpha
March 31, 2022

Nanobiotix S.A (NBTX) CEO Laurent Levy on Q4 2021 Results - Earnings Call Transcript

Nanobiotix S.A (NBTX) CEO Laurent Levy on Q4 2021 Results - Earnings Call Transcript more_horizontal


Search within

Pages Search Results: